Why Aduhelm, a new Alzheimer's treatment, isn't reaching many patients
Short Wave
00:00
The Controversial Approval of Aduhelm: Efficacy and Risks
This chapter explores the FDA's decision to approve Aduhelm, an Alzheimer's treatment, amidst debates about its limited effectiveness and risks. It features insights from healthcare professionals on the drug's modest benefits versus significant potential side effects, as well as the challenges faced by doctors in discussing these complexities with patients.
Transcript
Play full episode
